Physical markers & treatment of mental illness

In this episode, Alice Limonciel and Sabine Bahn discuss how to improve the tools for diagnosing and treating patients with mental illness, from depression to schizophrenia and bipolar disorder. Together, they discuss the relevance of omics to provide much needed physical diagnosis of these conditions, and the impact of metabolomics in this field.

Sabine Bahn

Sabine Bahn is a practicing psychiatrist and a professor of Neurotechnology at the University of Cambridge in the UK. She is Head of the Cambridge Center for Neuropsychiatric Research and co-founder of the company Psyomics.

Favorite metabolite

Learn more about Sabine Bahn here.
Cambridge Center for Neuropsychiatric Research |
Discover Psyomics here.

Paper discussed in this episode
Metabolomic Biomarker Signatures for Bipolar and Unipolar Depression
Jakub Tomasik, Scott J. Harrison, Nitin Rustogi, et al. JAMA Psychiatry. 2024;81(1):101-106. | doi:10.1001/jamapsychiatry.2023.4096

Sign up for The Metabolomist mailing list to be the first to hear about the latest episodes and news around metabolomics at

Finally available – Alice’s first book
The STORY principle – A guide to the biological interpretation of metabolomics
Also featuring some of the Metabolomists from Season 1
Available on Amazon and the biocrates webshop